Cargando…
Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682468/ https://www.ncbi.nlm.nih.gov/pubmed/38012154 http://dx.doi.org/10.1038/s41408-023-00948-x |
_version_ | 1785150982229852160 |
---|---|
author | Wang, Miao Cao, Han-Yu Tan, Kai-Wen Qiu, Qiao-Cheng Huang, Yuan-Hong Ge, Shuai-shuai Wang, Zi-Hao Chen, Jia Tang, Xiao-Wen Wu, De-Pei Xue, Sheng-Li Li, Zheng Dai, Hai-Ping |
author_facet | Wang, Miao Cao, Han-Yu Tan, Kai-Wen Qiu, Qiao-Cheng Huang, Yuan-Hong Ge, Shuai-shuai Wang, Zi-Hao Chen, Jia Tang, Xiao-Wen Wu, De-Pei Xue, Sheng-Li Li, Zheng Dai, Hai-Ping |
author_sort | Wang, Miao |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10682468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106824682023-11-30 Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study Wang, Miao Cao, Han-Yu Tan, Kai-Wen Qiu, Qiao-Cheng Huang, Yuan-Hong Ge, Shuai-shuai Wang, Zi-Hao Chen, Jia Tang, Xiao-Wen Wu, De-Pei Xue, Sheng-Li Li, Zheng Dai, Hai-Ping Blood Cancer J Correspondence Nature Publishing Group UK 2023-11-27 /pmc/articles/PMC10682468/ /pubmed/38012154 http://dx.doi.org/10.1038/s41408-023-00948-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correspondence Wang, Miao Cao, Han-Yu Tan, Kai-Wen Qiu, Qiao-Cheng Huang, Yuan-Hong Ge, Shuai-shuai Wang, Zi-Hao Chen, Jia Tang, Xiao-Wen Wu, De-Pei Xue, Sheng-Li Li, Zheng Dai, Hai-Ping Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study |
title | Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study |
title_full | Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study |
title_fullStr | Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study |
title_full_unstemmed | Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study |
title_short | Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study |
title_sort | venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with runx1::runx1t1: a retrospective propensity score matching study |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682468/ https://www.ncbi.nlm.nih.gov/pubmed/38012154 http://dx.doi.org/10.1038/s41408-023-00948-x |
work_keys_str_mv | AT wangmiao venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT caohanyu venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT tankaiwen venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT qiuqiaocheng venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT huangyuanhong venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT geshuaishuai venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT wangzihao venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT chenjia venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT tangxiaowen venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT wudepei venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT xueshengli venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT lizheng venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT daihaiping venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy |